Global Alzheimer’s Trial For China’s ‘Seaweed Drug’ Halted
Being Patient,
This Alzheimer’s drug has already been approved for use in China. The clinical trials that could lead to approval in the U.S.
This Alzheimer’s drug has already been approved for use in China. The clinical trials that could lead to approval in the U.S.
Being Patient reporter Simon Spichak, who researches the role of microbes and aging at APC Microbiome Ireland, University…